Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology

Written By Yiran Gan
Plasma Pyroglutamate - Modified Amyloid Beta Differentiates Amyloid Pathology - Wang et al. 2020

Plasma Pyroglutamate - Modified Amyloid Beta Differentiates Amyloid Pathology

Publication Date: 2020.05.04

Authors: PN Wang, KJ Lin, HC Liu, Ulf Andreasson, Kaj Blennow, Henrik Zetterberg, SY Yang

Journal: Alzheimer's Dement. 2020;12:e12029

© 2020 Wang, Lin, Liu, Andreasson, Blennow, Zetterberg and Yang

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Yiran Gan
Previous

Structure, Magnetic Property, Surface Morphology, and Surface Energy of Co40Fe40V10B10 Films on Si(100) Substrate
Next

Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease